The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: aldactone     Quarter: 2016Q3

Total Drug/Injury Combinations: 147     Number of Pages: 8

DRUGNAME PT EventCount
ALDACTONE Weight increased 1 view events
ALDACTONE A Alanine aminotransferase increased 1 view events
ALDACTONE A Aspartate aminotransferase increased 1 view events
ALDACTONE A Basilar artery occlusion 1 view events
Aldactone A Cholestasis 1 view events
ALDACTONE A Colon cancer 1 view events
Aldactone A Condition aggravated 1 view events
ALDACTONE A Depressed level of consciousness 1 view events
ALDACTONE A Embolic cerebral infarction 1 view events
ALDACTONE A Feeding disorder 1 view events
ALDACTONE A Hepatic failure 1 view events
ALDACTONE A Hepatic function abnormal 1 view events
ALDACTONE A Hyperkalaemia 1 view events
ALDACTONE A Nausea 1 view events
ALDACTONE A Oedema 1 view events
Aldactone A Platelet count decreased 1 view events
Aldactone A Pulmonary hypertension 1 view events
ALDACTONE A Renal impairment 1 view events
ALDACTONE A Tinnitus 1 view events
Aldactone A 25MG Electrocardiogram QT prolonged 1 view events

Total Drug/Injury Combinations: 147     Number of Pages: 8

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)